ELAN Q1 2022 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

Q1 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.2B-1.3% YoY

Gross Profit

$580M47.3% margin

Operating Income

$176M14.4% margin

Net Income

$51M4.2% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+10.2%

Cash Flow

Operating Cash Flow

-$62M

Free Cash Flow

-$88M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$16.3B

Total Liabilities

$8.6B

Stockholders' Equity

$7.6B

Cash & Equivalents

$342M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.2B	-1.3%
Gross Profit	$580M	$526M	+10.3%
Operating Income	$176M	$89M	+97.8%
Net Income	$51M	-$61M	+183.6%

Revenue Segments

Pet Health

$639M52%

Farm Animal

$569M46%

Contract Manufacturing

$17M1%

Geographic Segments

Non-US

$703M57%

UNITED STATES

$522M43%